Immunic, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $86.00K, a 30.08% decline year-over-year.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $123.00K.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $96.00K, a 26.15% decline year-over-year.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $130.00K.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $182.00K, a 136.36% increase from fiscal 2024.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $77.00K, a 40.31% decline from fiscal 2023.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $129.00K, a 29.12% decline from fiscal 2022.
- Immunic, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $182.00K, a 97.83% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $86.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $182.00K 10-K · filed 2026-02-26 | |
| 2025-06-30 | $123.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $77.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | $129.00K 10-K · filed 2025-03-31 | |
| 2023-06-30 | $96.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $182.00K 10-K · filed 2024-02-22 | |
| 2022-06-30 | $130.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $5.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $92.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |